President Joe Biden recently relaunched his Cancer Moonshot initiative. His passion for ending cancer is commendable. Unfortunately, the policies he has enacted will undermine his quest.
The Cancer Moonshot aims to reduce the death rate from cancer by 50 percent over the next 25 years by pouring money into cancer research and improving coordination to speed up research. “We’re going to end cancer as we know it. Mark my words,” he said in a speech this month.
Yet his signature legislative achievement, the Inflation Reduction Act, goes in the opposite direction—levying price controls on prescription drugs and gutting the ecosystem that underwrites drug discovery.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.
The Inflation Reduction Act Kills the Golden Goose That Could End Cancer
Sally C. Pipes
President Joe Biden recently relaunched his Cancer Moonshot initiative. His passion for ending cancer is commendable. Unfortunately, the policies he has enacted will undermine his quest.
The Cancer Moonshot aims to reduce the death rate from cancer by 50 percent over the next 25 years by pouring money into cancer research and improving coordination to speed up research. “We’re going to end cancer as we know it. Mark my words,” he said in a speech this month.
Yet his signature legislative achievement, the Inflation Reduction Act, goes in the opposite direction—levying price controls on prescription drugs and gutting the ecosystem that underwrites drug discovery.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.